Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2010 by Hospital Carlos III, Madrid.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Hospital Carlos III, Madrid
ClinicalTrials.gov Identifier:
NCT01066065
First received: February 9, 2010
Last updated: June 24, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2011
  Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)